These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23743806)

  • 1. Eligibility for percutaneous renal denervation: the importance of a systematic screening.
    Verloop WL; Vink EE; Voskuil M; Vonken EJ; Rookmaaker MB; Bots ML; Doevendans PA; Blankestijn PJ; Spiering W
    J Hypertens; 2013 Aug; 31(8):1662-8. PubMed ID: 23743806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of secondary hypertension in patients referred for renal denervation--the Copenhagen experience.
    Olsen LK; Kamper AL; Svendsen JH; Bang LE; Frimodt-Møller M; Kelbæk H; Sander M; Feldt-Rasmussen B
    Blood Press; 2014 Aug; 23(4):233-9. PubMed ID: 24437697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory blood pressure monitoring in kidney transplant patients: RETENAL study.
    Fernandez Fresnedo G; Franco Esteve A; Gómez Huertas E; Cabello Chaves V; Díz Gómez JM; Osorio Moratalla JM; Gallego Samper R; Gallego Valcárcel E; Campistol Plana JM; Marín Iranzo R; Arias Rodríguez M;
    Transplant Proc; 2012 Nov; 44(9):2601-2. PubMed ID: 23146468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Definition of 24 hour ambulatory blood pressure values corresponding to office blood pressure values of 130/80 mm Hg].
    Rihácek I; Soucek M; Frána P; Plachý M; Vasků A; Znojil V
    Vnitr Lek; 2008 Feb; 54(2):146-9. PubMed ID: 23687705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does home blood pressure allow for a better assessment of the white-coat effect than ambulatory blood pressure?
    Saladini F; Benetti E; Malipiero G; Casiglia E; Palatini P
    J Hypertens; 2012 Nov; 30(11):2118-24. PubMed ID: 23027180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal denervation in multiple renal arteries.
    Verloop WL; Vink EE; Spiering W; Blankestijn PJ; Doevendans PA; Bots ML; Vonken EJ; Voskuil M
    Eur J Clin Invest; 2014 Aug; 44(8):728-35. PubMed ID: 24931208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.
    ; ; ; ; ; Hermida RC; Smolensky MH; Ayala DE; Portaluppi F
    Chronobiol Int; 2013 Apr; 30(3):355-410. PubMed ID: 23517220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal denervation: results of a single-center cohort study.
    Luetkens JA; Wilhelm K; Düsing R; Woitas RP; Thomas D; Hundt F; Doerner J; Schild HH; Nähle CP
    Rofo; 2015 Jan; 187(1):36-41. PubMed ID: 25188311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of ambulatory blood pressure monitoring in managing hypertension according to different treatment guidelines.
    Addison C; Varney S; Coats A
    J Hum Hypertens; 2001 Aug; 15(8):535-8. PubMed ID: 11494091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the presence of accessory renal arteries affect the efficacy of renal denervation?
    Id D; Kaltenbach B; Bertog SC; Hornung M; Hofmann I; Vaskelyte L; Sievert H
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1085-91. PubMed ID: 24156968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain.
    Gorostidi M; Sarafidis PA; de la Sierra A; Segura J; de la Cruz JJ; Banegas JR; Ruilope LM;
    Am J Kidney Dis; 2013 Aug; 62(2):285-94. PubMed ID: 23689071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal artery denervation for treating refractory hypertension].
    Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
    Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features, anthropometric characteristics, and racial influences on the 'white-coat effect' in a single-centre cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring.
    Gualdiero P; Niebauer J; Addison C; Clark SJ; Coats AJ
    Blood Press Monit; 2000 Apr; 5(2):53-7. PubMed ID: 10828890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the white-coat effect among hypertensive patients presumed to be at goal.
    Bookstaver DA; Hatzigeorgiou C
    Ann Pharmacother; 2011 Jul; 45(7-8):910-5. PubMed ID: 21750311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The white-coat effect is an independent predictor of myocardial ischemia in resistant hypertension.
    Modolo R; Ruggeri Barbaro N; de Faria AP; Rodrigues Sabbatini A; Paganelli MO; Fontana V; Moreno H
    Blood Press; 2014 Oct; 23(5):276-80. PubMed ID: 24571101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective.
    Doumas M; Anyfanti P; Bakris G
    J Hypertens; 2012 May; 30(5):874-6. PubMed ID: 22495128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement of blood pressure in consultation and automated mesurement (BPTru(®)) to evaluate the white coat effect].
    García-Donaire JA; Dalfó Baqué A; Sanclemente Ansó C; Urdiales Castillo D; Martínez Debén F; Ortega López N; Pizarro Núñez JL; Martín Oterino JÁ; García-Norro Herreros J; Mediavilla García JD; Vara González LA; Prieto Díaz MÁ; Vila Coll MA; Gómez Fernández P; Rossique Delmas P; Gascón Becerril R; Pérez Álvarez R; Delgado Zamora R; de Vega Santos T; Cerezo Olmos C; Segura de La Morena J; Ruilope LM
    Med Clin (Barc); 2012 May; 138(14):597-601. PubMed ID: 22440145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of the white-coat effect at multiple visits before and during treatment.
    Verberk WJ; Kroon AA; Thien T; Lenders JW; van Montfrans GA; Smit AJ; de Leeuw PW
    J Hypertens; 2006 Dec; 24(12):2357-63. PubMed ID: 17082716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.